You run everywhere, you work, you look after the family, and you dream of having time to practice? You're not alone!

Noom, a health and longevity platform, launched Face Scan and Future Me in October 2025, available for free to use via the app. Face Scan is powered by NuraLogix, while Future Me uses Haut.ai. Let's ...

You want to get back into shape, but the thought of joining a gym is already making you break out in a cold sweat? Good news: ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

It’s a Natty Wolf pop-up, and Broadsheet Access members are invited to celebrate the launch of her bestselling debut cookbook ...

Marketers are positioning weight-loss shots as cosmetic elixirs for anyone who wants to lose a few pounds. Doctors warn that such patients could put themselves at risk for potentially serious side ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Weight-loss drugs are coming for a new kind of customer. “You don’t need to be obese to start a GLP-1,” reads an ad from a telehealth startup, the words scrawled in icing on a cake. Another one ...

Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...

Co-Diagnostics, Inc.  ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara ...